Additionally, the expression of ACE2 and TMPRSS2 was lower in children's airways than smokers and patients with COPD, suggesting a plausible reason for the difference in the severity of COVID-19 disease among different groups of patients [56]. This evidence concerns the gene ACE2 and chronic obstructive pulmonary disease.